Intra-Cellular Therapies, Inc. (ITCI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 74.01 |
| Open | 73.71 |
| Bid | 73.00 x 200 |
| Ask | 73.11 x 100 |
| Day's Range | 72.41 - 74.11 |
| 52 Week Range | 45.50 - 84.89 |
| Volume | |
| Avg. Volume | 973,385 |
| Market Cap | 7.721B |
| Beta (5Y Monthly) | 1.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
10 Best Performing Biotech ETFs in 2024
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]
- Investor's Business Daily
Biotech Leader Intra-Cellular Soars 23%, Breaks Out Past Latest Buy Point
Intra-Cellular stock: Shares rocketed more than 23% Tuesday, sending them past their latest buy point on the stock market today.
- Zacks
Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
Intra-Cellular (ITCI) jumps 23% after achieving key goals in the late-stage study evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of MDD.
© 2024 Yahoo. All rights reserved.